Previous 10 | Next 10 |
Gainers: Insignia Systems (NASDAQ:ISIG) +106%. Energy Focus (NASDAQ:EFOI) +65%. Virpax (NASDAQ:VRPX) +26%. Aziyo (NASDAQ:AZYO) +26%. Digital World Acquisition (NASDAQ:DWACU) +20%. Digital World Acquisition (NASDAQ:DWAC) +20%. RLX Technology (NYSE:RLX) +20%. The Lovesac (NASDAQ:LOVE) +19%. Pho...
SILVER SPRING, Md., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (the “Company”) today announced that it has entered into a definitive agreement to sell securities in a private placement that is expected to result in gross proceeds to the Company of approximately $1...
SILVER SPRING, Md., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the company ...
Aziyo Biologics, Inc. (AZYO) Q3 2021 Earnings Conference Call November 09, 2021 4:30 PM ET Company Participants Leigh Salvo - IR, Gilmartin Group LLC Ronald Lloyd - President and CEO Matthew Ferguson - CFO Conference Call Participants David Rescott - Truist Securities Presentation Operator Go...
Aziyo Biologics (NASDAQ:AZYO): Q3 GAAP EPS of -$0.81 misses by $0.19. Revenue of $11.49M (-2.4% Y/Y) in-line. Press Release For further details see: Aziyo Biologics EPS misses by $0.19, revenue in-line
SILVER SPRING, Md., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial res...
Gainers: Inspira Technologies (NASDAQ:IINN) +54%, SeqLL (NASDAQ:SQL) +46%, Ocugen (NASDAQ:OCGN) +27%, Aziyo Biologics (NASDAQ:AZYO) +15%, Roivant Sciences (NASDAQ:ROIV) +14%. Losers: Evaxion Biotech (NASDAQ:EVAX) -14%, Kiromic BioPharma (...
SILVER SPRING, Md., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it was ...
Gainers: Grove (NASDAQ:GRVI) +62%. NRx Pharmaceuticals (NASDAQ:NRXP) +35%. Connect Biopharma (NASDAQ:CNTB) +23%. Huttig Building Products (NASDAQ:HBP) +20%. KORE (NYSE:KORE) +20%. DarioHealth (NASDAQ:DRIO) +19%. Broadwind (NASDAQ:BWEN) +19%. Cemtrex (NASDAQ:CETX) +17%. Annovis (NYSE:ANVS) +17...
SILVER SPRING, Md., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the Company...
News, Short Squeeze, Breakout and More Instantly...
Aziyo Biologics Inc. Company Name:
AZYO Stock Symbol:
NASDAQ Market:
– Company to begin trading under new ticker symbol “ELUT” – SILVER SPRING, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”) today announced a change of the Company’s name to Elutia Inc. The rebranding ref...
Case provides first histologic evidence that CanGaroo can catalyze development of new healthy tissue layer within an existing cardiac implantable electronic device (CIED) pocket SILVER SPRING, Md., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”...
Negotiating multiple LOIs to divest Orthopedic business CanGaroo ® RM 510(k) resubmission to the FDA remains on track SimpliDerm ® quarterly net sales up 32% year-over-year Successful transfer of Cardiovascular product distribution to LeMaitre Vascular ...